These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8310709)

  • 1. Preferential elimination of pivalate with supplemental carnitine via formation of pivaloylcarnitine in man.
    Melegh B; Sumegi B; Sherry AD
    Xenobiotica; 1993 Nov; 23(11):1255-61. PubMed ID: 8310709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential excretion of xenobiotic acyl-esters of carnitine due to administration of pivampicillin and valproate.
    Melegh B; Kerner J; Jaszai V; Bieber LL
    Biochem Med Metab Biol; 1990 Feb; 43(1):30-8. PubMed ID: 2106908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pivampicillin-promoted excretion of pivaloylcarnitine in humans.
    Melegh B; Kerner J; Bieber LL
    Biochem Pharmacol; 1987 Oct; 36(20):3405-9. PubMed ID: 3675603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of carnitine and carnitine precursors lysine, epsilon-N-trimethyllysine, and gamma-butyrobetaine in drug-induced carnitine depletion.
    Melegh B; Pap M; Bock I; Rebouche CJ
    Pediatr Res; 1993 Oct; 34(4):460-4. PubMed ID: 8255678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of pivaloylcarnitine in isolated rat heart cells.
    Diep QN; Brørs O; Bøhmer T
    Biochim Biophys Acta; 1995 Nov; 1259(2):161-5. PubMed ID: 7488636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivalate-generating prodrugs and carnitine homeostasis in man.
    Brass EP
    Pharmacol Rev; 2002 Dec; 54(4):589-98. PubMed ID: 12429869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine content of red blood cells of human subjects treated with pivampicillin and carnitine.
    Melegh B; Jászai V
    Acta Paediatr Hung; 1991; 31(2):255-61. PubMed ID: 1867892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of pivaloylcarnitine in pediatric patients with hypocarnitinemia after long-term administration of pivalate-containing antibiotics.
    Nakajima Y; Ito T; Maeda Y; Ichiki S; Sugiyama N; Mizuno M; Makino Y; Sugiura T; Kurono Y; Togari H
    Tohoku J Exp Med; 2010 Aug; 221(4):309-13. PubMed ID: 20651467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefetamet pivoxil treatment causes loss of carnitine reserves that can be prevented by exogenous carnitine administration.
    Pap M; Kopcsányi G; Bieber LL; Gage DA; Melegh B
    J Nutr Biochem; 1999 Nov; 10(11):670-3. PubMed ID: 15539265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of cefditoren pivoxil on carnitine metabolism in pediatric patients].
    Fujii R; Chiba S; Numazaki K; Mori T; Terashima I; Meguro H; Mori A; Toyonaga Y; Sunakawa K; Satoh Y
    Jpn J Antibiot; 1993 Oct; 46(10):926-37. PubMed ID: 8254895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil.
    Brass EP; Mayer MD; Mulford DJ; Stickler TK; Hoppel CL
    Clin Pharmacol Ther; 2003 Apr; 73(4):338-47. PubMed ID: 12709724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of pivaloylcarnitine in heart and brown adipose tissue in the rat.
    Diep QN; Bøhmer T; Skrede S
    Biochim Biophys Acta; 1995 Jan; 1243(1):65-70. PubMed ID: 7827109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine administration ameliorates the changes in energy metabolism caused by short-term pivampicillin medication.
    Melegh B; Pap M; Molnár D; Masszi G; Kopcsányi G
    Eur J Pediatr; 1997 Oct; 156(10):795-9. PubMed ID: 9365072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores.
    Nakashima M; Uematsu T; Oguma T; Yoshida T; Mizojiri K; Matsuno S; Yamamoto S
    Antimicrob Agents Chemother; 1992 Apr; 36(4):762-8. PubMed ID: 1503438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnitine import to isolated hepatocytes and synthesis are accelerated in pivalate-treated rats.
    Nakajima H; Inoue F; Kizaki Z; Terada N; Okochi M; Kinugasa A; Sawada T
    J Nutr; 1999 Sep; 129(9):1688-91. PubMed ID: 10460205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy.
    Holme E; Greter J; Jacobson CE; Lindstedt S; Nordin I; Kristiansson B; Jodal U
    Lancet; 1989 Aug; 2(8661):469-73. PubMed ID: 2570185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocarnitinaemia induced by sodium pivalate in the rat is associated with left ventricular dysfunction and impaired energy metabolism.
    Broderick TL
    Drugs R D; 2006; 7(3):153-61. PubMed ID: 16752941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine status and safety after administration of S-1108, a new oral cephem, to patients.
    Shimizu K; Saito A; Shimada J; Ohmichi M; Hiraga Y; Inamatsu T; Shimada K; Tanimura M; Fujita Y; Nishikawa T
    Antimicrob Agents Chemother; 1993 May; 37(5):1043-9. PubMed ID: 8517691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.
    Totsuka K; Shimizu K; Konishi M; Yamamoto S
    Antimicrob Agents Chemother; 1992 Apr; 36(4):757-61. PubMed ID: 1503437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine and glucuronic acid conjugates of pivalic acid.
    Vickers S; Duncan CA; White SD; Ramjit HG; Smith JL; Walker RW; Flynn H; Arison BH
    Xenobiotica; 1985 Jun; 15(6):453-8. PubMed ID: 4036169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.